ArrowArtboardCreated with Sketch.Title ChevronCrossEye IconIcon FacebookIcon LinkedinShapeCreated with Sketch.Icon Mail ContactPath LayerIcon MailMenu BurgerPositive ArrowIcon PrintIcon SearchSite TitleTitle ChevronIcon Twitter

Shionogi drug can kill viruses in 1 day

OSAKA -- Shionogi & Co. will release what it calls the world's first one-day treatment for influenza in Japan as early as 2018.

     Unlike conventional offerings, the new drug prevents the flu virus from propagating. It inhibits the activity of enzymes that aid the propagation of viruses that enter the body through the throat or nose. The drug is taken orally.

     Current flu treatments include Tamiflu, from Swiss drugmaker Roche. But Tamiflu does not halt the spread of the virus and must be taken for five days or so.

     Shionogi has conducted phase I clinical trials in Japan, testing the drug on healthy people to evaluate its safety. The Japanese company plans to begin phase II trials on hundreds of subjects as early as November, once the flu season begins, to confirm efficacy.

     The health ministry recently put the drug into a fast-track approval process for quickly bringing groundbreaking new treatments to market.


You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

Subscribe to get unlimited access to all articles.

Get unlimited access
NAR site on phone, device, tablet

{{sentenceStarter}} {{numberReadArticles}} free article{{numberReadArticles-plural}} this month

Stay ahead with our exclusives on Asia; the most dynamic market in the world.

Benefit from in-depth journalism from trusted experts within Asia itself.

Try 3 months for $9

Offer ends September 30th

Your trial period has expired

You need a subscription to...

See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

See all offers
NAR on print phone, device, and tablet media